Compound information
- Natural Products
- ZC1806461
- Molecular Formula
- C21H24O6
- Molecular Weight
- 372.157288488 g/mol
- Structure
-
- IUPAC Name
- (1E,6E)-1-[(1R,5R)-4-hydroxy-5-methoxy-cyclohex-3-en-1-yl]-7-(4-hydroxy-3-methoxy-phenyl)hepta-1,6-diene-3,5-dione
- InChI
- InChI=1S/C21H24O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-5,7-11,15,21,24-25H,6,12-13H2,1-2H3/b7-3+,8-4+/t15-,21-/m1/s1
- InChI Key
- CRCHRNHFHJDFAA-MMYKLIQSSA-N
- SMILES
- COc1cc(/C=C/C(=O)CC(=O)/C=C/[C@@H]2CC=C(O)[C@H](OC)C2)ccc1O
- Source
- ZINC000100037298
Warheads
- Michael Acceptor
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 27 | Ring Count | 2 |
| Heteroatom Count | 6 | Rotatable Bond Count | 8 |
| Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 2 |
| Topological Polar Surface Area | 93.06 Å2 | LogP | 2.943 |
| LogS | -3.835 | LogD | 1.788 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.006 | Pgp substrate | 0.002 |
| HIA | 0.969 | F20 % | 0.993 |
| F30 % | 0.903 | Caco-2 | -4.76 |
| MDCK | -4.963 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.45 | PPB | 83.448 |
| VD | 0.471 | Fu | 1.256 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.004 | CYP1A2 substrate | 0.44 |
| CYP2A6 substrate | 0.409 | CYP2B6 substrate | 0.403 |
| CYP2C19 inhibitor | 0.009 | CYP2C19 substrate | 0.375 |
| CYP2C8 substrate | 0.616 | CYP2C9 inhibitor | 0.023 |
| CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.029 |
| CYP2D6 substrate | 0.262 | CYP2E1 substrate | 0.161 |
| CYP3A4 inhibitor | 0.238 | CYP3A4 substrate | 0.409 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.965 | CL | 11.197 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.005 | Hepatotoxicity | 0.987 |
| Mutagenicity | 0.185 | Rat Oral Acute Toxicity | 0.44 |
| FDAMDD | 0.674 | Skin Sensitization | 0.956 |
| Carcinogenicity | 0.828 | Eye Corrosion | 0.933 |
| Eye Irritation | 0.964 | Respiratory Toxicity | 0.815 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | 0.844 | IGC50 | 4.614 |
| LC50FM | 6.003 | LC50DM | 5.944 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.396 | NR-AR-LBD | 0.625 |
| NR-AhR | 0.021 | NR-Aromatase | 0.45 |
| NR-ER | 0.602 | NR-ER-LBD | 0.537 |
| NR-PPAR-gamma | 0.948 | SR-ARE | 0.898 |
| SR-ATAD5 | 0.834 | SR-HSE | 0.397 |
| SR-MMP | 0.699 | SR-p53 | 0.585 |
Similar covalent drugs
No similar covalent drugs found for this compound.